Shane V. Hegarty

1.5k total citations
27 papers, 989 citations indexed

About

Shane V. Hegarty is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Shane V. Hegarty has authored 27 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 9 papers in Neurology. Recurrent topics in Shane V. Hegarty's work include Nerve injury and regeneration (8 papers), TGF-β signaling in diseases (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Shane V. Hegarty is often cited by papers focused on Nerve injury and regeneration (8 papers), TGF-β signaling in diseases (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Shane V. Hegarty collaborates with scholars based in Ireland, United Kingdom and United States. Shane V. Hegarty's co-authors include Gerard W. O’Keeffe, Aideen M. Sullivan, Zhigang He, Yuanyuan Liu, Yiming Zhang, Philip R. Williams, Junjie Zhu, Xiaosong Gu, Louise Collins and Yi Li and has published in prestigious journals such as Cell, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Shane V. Hegarty

27 papers receiving 973 citations

Peers

Countries citing papers authored by Shane V. Hegarty

Since Specialization

Citations

This map shows the geographic impact of Shane V. Hegarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shane V. Hegarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shane V. Hegarty more than expected).

Fields of papers citing papers by Shane V. Hegarty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shane V. Hegarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shane V. Hegarty. The network helps show where Shane V. Hegarty may publish in the future.

Co-authorship network of co-authors of Shane V. Hegarty

This figure shows the co-authorship network connecting the top 25 collaborators of Shane V. Hegarty. A scholar is included among the top collaborators of Shane V. Hegarty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shane V. Hegarty. Shane V. Hegarty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of KCC2 therapeutics to treat neurological disorders 2024 ·Frontiers in Molecular Neuroscience ·Shilpa D. Kadam, Shane V. Hegarty	2
2	K⁺/Cl⁻ co-transporter-2 upmodulation: a multi-modal therapy to treat spinal cord injury 2022 ·Neural Regeneration Research ·Shane V. Hegarty, Joanna Stanicka	3
3	Lipidomics dataset of PTEN deletion-induced optic nerve regeneration mouse model 2020 ·SHILAP Revista de lepidopterología ·(unknown), Shane V. Hegarty, Zhigang He, Sanjoy K. Bhattacharya	6
4	Viral vectors for neuronal cell type-specific visualization and manipulations 2020 ·Current Opinion in Neurobiology ·Yuanyuan Liu, Shane V. Hegarty, (unknown), Fan Wang, Zhigang He	16
5	Reactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations 2018 ·Cell ·Bo Chen, Yi Li, Bin Yu, Zicong Zhang, Benedikt Brommer, Philip R. Williams, Yuanyuan Liu, Shane V. Hegarty, Songlin Zhou, Junjie Zhu, Hong Guo, Yi Lu, Yiming Zhang, Xiaosong Gu, Zhigang He	167
6	Exposure to Hypertensive Disorders of Pregnancy Increases the Risk of Autism Spectrum Disorder in Affected Offspring 2017 ·Molecular Neurobiology ·Eileen A. Curran, Gerard W. O’Keeffe, (unknown), Gerard M. Moloney, Shane V. Hegarty, Deirdre M. Murray, Ali S. Khashan, Louise C. Kenny	40
7	Effects of intracerebral neurotrophic factor application on motor symptoms in Parkinson's disease: A systematic review and meta-analysis 2017 ·Parkinsonism & Related Disorders ·Shane V. Hegarty, David J. Lee, Gerard W. O’Keeffe, Aideen M. Sullivan	22
8	Endocytosis contributes to BMP2-induced Smad signalling and neuronal growth 2017 ·Neuroscience Letters ·Shane V. Hegarty, Aideen M. Sullivan, Gerard W. O’Keeffe	11
9	Zeb2 is a negative regulator of midbrain dopaminergic axon growth and target innervation 2017 ·Scientific Reports ·Shane V. Hegarty, Séan Wyatt, Laura Howard, Elke Stappers, Danny Huylebroeck, Aideen M. Sullivan, Gerard W. O’Keeffe	18
10	Romidepsin induces caspase-dependent cell death in human neuroblastoma cells 2017 ·Neuroscience Letters ·Shane V. Hegarty, (unknown), (unknown), (unknown), Aideen M. Sullivan, Gerard W. O’Keeffe	9
11	Protocol for evaluation of neurotrophic strategies in Parkinson 2016 ·Journal of Biological Methods ·Shane V. Hegarty, Aideen M. Sullivan, Gerard W. O’Keeffe	10
12	A Small Molecule Activator of p300/CBP Histone Acetyltransferase Promotes Survival and Neurite Growth in a Cellular Model of Parkinson’s Disease 2016 ·Neurotoxicity Research ·Shane V. Hegarty, (unknown), (unknown), Joanna Stanicka, Aideen M. Sullivan, Gerard W. O’Keeffe	30
13	The Epigenome as a therapeutic target for Parkinson's disease 2016 ·Neural Regeneration Research ·Shane V. Hegarty, Gerard W. O’Keeffe, Aideen M. Sullivan	32
14	Zeb2: A multifunctional regulator of nervous system development 2015 ·Progress in Neurobiology ·Shane V. Hegarty, Aideen M. Sullivan, Gerard W. O’Keeffe	84
15	Canonical BMP–Smad Signalling Promotes Neurite Growth in Rat Midbrain Dopaminergic Neurons 2014 ·NeuroMolecular Medicine ·Shane V. Hegarty, Louise Collins, (unknown), Sarah L. Roche, Séan Wyatt, Aideen M. Sullivan, Gerard W. O’Keeffe	41
16	Class-IIa Histone Deacetylase Inhibition Promotes the Growth of Neural Processes and Protects Them Against Neurotoxic Insult 2014 ·Molecular Neurobiology ·Louise Collins, (unknown), (unknown), Shane V. Hegarty, Aideen M. Sullivan, Gerard W. O’Keeffe	32
17	Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson′s disease 2014 ·Neural Regeneration Research ·Gerard W. O’Keeffe, Aideen M. Sullivan, Shane V. Hegarty	41
18	Midbrain dopaminergic neurons: A review of the molecular circuitry that regulates their development 2013 ·Developmental Biology ·Shane V. Hegarty, Aideen M. Sullivan, Gerard W. O’Keeffe	145
19	Ventral midbrain neural stem cells have delayed neurogenic potential in vitro 2013 ·Neuroscience Letters ·Shane V. Hegarty, (unknown), Aideen M. Sullivan, Gerard W. O’Keeffe	1
20	BMP2 and GDF5 induce neuronal differentiation through a Smad dependant pathway in a model of human midbrain dopaminergic neurons 2013 ·Molecular and Cellular Neuroscience ·Shane V. Hegarty, Aideen M. Sullivan, Gerard W. O’Keeffe	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact